NVS Novartis AG
- 97.319
- -0.181-0.19%
Novartis AG News
Analysts Have Conflicting Sentiments on These Healthcare Companies: Carl Zeiss Meditec (GB:0DHC), Siemens Healthineers AG (OtherSEMHF) and Novartis AG (Six Swiss: CH:NOVN)
Novartis Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcidion Group Limited (ALC) and Novartis AG (Six Swiss: CH:NOVN)
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Analysts Offer Insights on Healthcare Companies: Novartis AG (Six Swiss: CH:NOVN), Carl Zeiss Meditec (GB:0DHC) and Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (AU:RMD)
Vertex Pharma Upgraded at Evercore on Alpine Immune Deal
Analysts Offer Insights on Healthcare Companies: Shop Apotheke Europe NV (GB:0RJT), Stryker (SYK) and Novartis AG (Six Swiss: CH:NOVN)
Analysts Offer Insights on Healthcare Companies: Novartis AG (NOVN) and Sigma Healthcare Ltd (Frankfurt: DE:S5YA)
Analysts Offer Insights on Healthcare Companies: Novartis AG (NOVN) and Biophytis SA (Frankfurt: DE:6XB)
BMO Capital Initiates Novartis at Market Perform Rating With $114 Price Target
BMO Capital Initiates Coverage On Novartis With Market Perform Rating, Announces Price Target of $114
Novartis Analyst Ratings
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Morgan Stanley Initiates Coverage On Novartis With Equal-Weight Rating, Announces Price Target of $114
Novartis Analyst Ratings
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Novartis Analyst Ratings
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Wedbush Downgrades Chinook Therapeutics to Neutral From Outperform as Sale to Novartis Draws Closer; Keeps $42 Price Target
Analysis
Price Target
No Data
